What is Lifesci Capital’s Estimate for VERA Q2 Earnings?
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2025 earnings per share estimates for shares of Vera Therapeutics in a research report issued on Monday, June 2nd. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings per share of ($0.82) for the quarter. The […]
